Amalgamated Bank Cuts Position in STAAR Surgical (NASDAQ:STAA)

Amalgamated Bank reduced its stake in STAAR Surgical (NASDAQ:STAA) by 2.8% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 14,590 shares of the medical instruments supplier’s stock after selling 418 shares during the period. Amalgamated Bank’s holdings in STAAR Surgical were worth $542,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in STAA. Swiss National Bank increased its stake in STAAR Surgical by 0.8% in the first quarter. Swiss National Bank now owns 77,100 shares of the medical instruments supplier’s stock valued at $2,951,000 after purchasing an additional 600 shares during the last quarter. Russell Investments Group Ltd. increased its stake in STAAR Surgical by 1.5% in the first quarter. Russell Investments Group Ltd. now owns 36,931 shares of the medical instruments supplier’s stock valued at $1,406,000 after purchasing an additional 555 shares during the last quarter. ProShare Advisors LLC increased its stake in STAAR Surgical by 8.4% in the first quarter. ProShare Advisors LLC now owns 9,892 shares of the medical instruments supplier’s stock valued at $379,000 after purchasing an additional 763 shares during the last quarter. State Board of Administration of Florida Retirement System grew its position in shares of STAAR Surgical by 11.2% during the first quarter. State Board of Administration of Florida Retirement System now owns 15,441 shares of the medical instruments supplier’s stock worth $591,000 after acquiring an additional 1,560 shares during the last quarter. Finally, Covestor Ltd grew its position in shares of STAAR Surgical by 38.9% during the first quarter. Covestor Ltd now owns 2,690 shares of the medical instruments supplier’s stock worth $103,000 after acquiring an additional 754 shares during the last quarter. 96.70% of the stock is currently owned by hedge funds and other institutional investors.

STAAR Surgical Price Performance

Shares of NASDAQ STAA opened at $26.66 on Friday. The stock has a fifty day moving average price of $31.29 and a 200 day moving average price of $37.28. STAAR Surgical has a 1-year low of $26.62 and a 1-year high of $52.68. The company has a market cap of $1.31 billion, a PE ratio of 60.59 and a beta of 0.61.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on STAA. Canaccord Genuity Group lowered their target price on shares of STAAR Surgical from $41.00 to $31.00 and set a “hold” rating on the stock in a research report on Friday, November 1st. Needham & Company LLC restated a “hold” rating on shares of STAAR Surgical in a research report on Thursday, October 31st. Finally, Stifel Nicolaus lowered their target price on shares of STAAR Surgical from $50.00 to $44.00 and set a “buy” rating on the stock in a research report on Monday, August 26th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $43.33.

About STAAR Surgical

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.